Han Yao

The paper introduces CauNagi, a causal machine learning tool, to identify causal drivers of VEXAS syndrome using single-cell transcriptomic data, revealing key regulatory hubs involved in myeloid dysfunction.

This study identifies PD-1 palmitoylation, its regulatory enzyme, and develops a peptide inhibitor to target PD-1 expression for cancer immunotherapy.